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Abstract
Human metapneumovirus (hMPV) is a leading cause of acute respiratory tract infection in infants, as well as in the elderly
and immunocompromised patients. No effective treatment or vaccine for hMPV is currently available. A recombinant hMPV
lacking the G protein (rhMPV-DG) was recently developed as a potential vaccine candidate and shown to be attenuated in
the respiratory tract of a rodent model of infection. The mechanism of its attenuation, as well as the role of G protein in
modulation of hMPV-induced cellular responses in vitro, as well as in vivo, is currently unknown. In this study, we found that
rhMPV-DG-infected airway epithelial cells produced higher levels of chemokines and type I interferon (IFN) compared to
cells infected with rhMPV-WT. Infection of airway epithelial cells with rhMPV-DG enhanced activation of transcription factors
belonging to the nuclear factor (NF)-kB and interferon regulatory factor (IRF) families, as revealed by increased nuclear
translocation and/or phosphorylation of these transcription factors. Compared to rhMPV-WT, rhMPV-DG also increased IRF-
and NF-kB-dependent gene transcription, which was reversely inhibited by G protein expression. Since RNA helicases have
been shown to play a fundamental role in initiating viral-induced cellular signaling, we investigated whether retinoic
induced gene (RIG)-I was the target of G protein inhibitory activity. We found that indeed G protein associated with RIG-I
and inhibited RIG-I-dependent gene transcription, identifying an important mechanism by which hMPV affects innate
immune responses. This is the first study investigating the role of hMPV G protein in cellular signaling and identifies G as an
important virulence factor, as it inhibits the production of important immune and antiviral mediators by targeting RIG-I, a
major intracellular viral RNA sensor.
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Introduction
Human metapneumovirus (hMPV) is a leading cause of both
upper and lower respiratory tract infections in infants, elderly and
immunocompromised patients worldwide [1]. It is an enveloped,
nonsegmented, negative-strand RNA virus, belonging to the
Paramyxoviridae family, expressing three putative viral membrane
proteins, the fusion protein F, the attachment glycoprotein G and
the small hydrophobic protein SH [2]. The role of G protein in
viral replication was recently investigated both in vitro and in vivo.
Recombinant hMPV (rhMPV) in which the G protein was deleted
(rhMPV-DG) exhibited reduced replication in the upper and lower
respiratory tract of Syrian hamsters and African green monkeys
[3,4]. The mechanism(s) underlying rhMPV-DG attenuation, as
well as the role of the hMPV G protein in modulating host cell
responses are largely unknown.
Sequence analysis of hMPV G protein suggests that it is a type
II mucin-like glycosylated protein [2]. The membrane anchor of G
protein is proximal to the N termini and its C termini is oriented
externally. Although the postulated function of G protein is for
attachment, it is not the only attachment protein since hMPV F
protein alone is sufficient to mediate attachment and fusion in
absence of other surface proteins [3,5]. Although the reduced
attachment ability of G deleted mutant might be the reason for the
observed attenuation of rhMPV-DG in vivo, it is also possible that
hMPV G protein may have anti-viral function by suppressing the
secretion of pro-inflammatory and/or antiviral molecules upon
infection, similar to what has been recently shown for the
respiratory syncytial virus (RSV) G protein. RSV lacking G
protein induces more cytokines in viral-infected monocytes and
human lung epithelial cells, compared to WT RSV [6,7].
Increased CC and CXC chemokine expression by G protein
deletion was also observed in a BALB/c mouse model of RSV
infection [8]. The mechanism for RSV G protein anti-inflamma-
tory activity is not clear.
In this study we investigated whether G protein could modulate
host innate immune responses following infection with hMPV.
Our results show that G protein indeed plays a role in regulating
the signaling pathways leading to the production of pro-
inflammatory molecules and type I IFN by affecting activation
of NF-kB and IRF, two key transcription factors involved in IFN,
cytokine and chemokine gene expression.
Two RNA helicases, retinoic inducible gene (RIG)-I and
melanoma differentiation associated gene (MDA)-5 have been
identified to be essential for IFN induction by several viruses
including NDV, Sendai, HCV and RSV [9–11]. We have recently
PLoS Pathogens | www.plospathogens.org 1 May 2008 | Volume 4 | Issue 5 | e1000077shown that RIG-I plays a major role in hMPV-induced cellular
signaling [12]. Both RIG-I and MDA-5 share a helicase domain,
that is required for their interaction with viral RNA [9,13], and a
CARD domain, that mediates their interaction with the adaptor
molecule IPS-1/MAVS/VISA/Cardif, leading to subsequent
activation of downstream signaling molecules such as IRFs, NF-
kB and AP-1 [14,15]. In this study, we found that hMPV G
protein interacts with RIG-I and blocks RIG-I-, but not MDA-5-
or MAVS-dependent gene transcription, identifying G as an
important virulence factor, responsible for inhibiting innate
immune responses to hMPV infection.
Results
Generation of recombinant hMPV
To investigate the role of hMPV glycoprotein G in hMPV-
induced cellular responses, we generated wild-type (WT) recom-
binant hMPV, as well as hMPV lacking G protein (DG), using a
reverse genetic system approach [3,16]. To verify whether G was
properly deleted, viral RNA was prepared and subsequently
subjected to reverse transcriptase polymerase chain reaction (RT-
PCR) using paired primers for G or SH gene amplification, as
described in Methods. As expected, there was no band
corresponding to amplified G in rhMPV-DG, while SH gene,
used as positive control, was detected from both rhMPV-WT and
rhMPV-DG (Fig. 1A).
We next determined whether viral replication of the recombi-
nant viruses was similar to the parental Canadian hMPV83 isolate.
To do so, LLC-MK2 cells were infected with hMPV, naı ¨ve or
recombinant, at MOI of 0.1. At 5 days p.i, the naı ¨ve hMPV and
rhMPV-WT were harvested. We found that the titers of naı ¨ve
hMPV and rhMPV-WT were essentially the same, while viral
titers of rhMPV-DG were slightly lower, between two and three
fold less than naı ¨ve hMPV and rhMPV-WT at all time points
tested. A similar difference was noted when viruses were grown in
Vero cells. To determine whether the initial replication phase of
the WT and DG mutant viruses in airway epithelial cells, the
target cell of hMPV infection, was similar, A549 cells were infected
with rhMPV-WT or -DG at MOI of 2 and harvested at different
time post-infection (p.i.) to measure viral titers and determine viral
antigen expression. Immunofluorescence analysis using anti-
hMPV polyclonal antibody showed that the percentage of cells
Figure 1. Characterization of recombinant viruses. (A) Verifica-
tion of G protein deletion. Viral RNA extracted from purified viruses was
subjected to RT-PCR using paired primers for G or SH genes. PCR
products were then analyzed on a 1% agarose gel. Numbers on the left
side represent molecular weight marker size expressed in kilobase (Kb).
(B) F protein expression analysis in infected cells. A549 cells were
infected with rhMPV-WT or rhMPV-DG, MOI of 2, and harvested to
prepare total cell lysates at the indicated times. Equal amounts of
protein were subjected to SDS-PAGE, followed by Western blot using a
monoclonal antibody against hMPV F protein. The results are the
representative of three independent experiments. Densitometric
analysis of band intensity was performed using the histogram function
of Adobe Photoshop.
doi:10.1371/journal.ppat.1000077.g001
Author Summary
Human metapneumovirus (hMPV), a member of the
Paramyxoviridae family, is an important cause of respira-
tory morbidity throughout life. The contribution of viral-
specific proteins to the pathogenesis of hMPV infection
and immune evasion is largely unknown. Previous work
has suggested that the glycoprotein G of hMPV is not
necessary for the process of viral fusion and attachment to
host cells, and a recombinant hMPV lacking the G protein
(rhMPV-DG) shows an attenuated phenotype in the
respiratory tract of animal models of infection. Airway
epithelial cells, a major component of the innate immune
system, are a primary target of hMPV infection. In this
study, we show that hMPV G protein functions as a major
inhibitory factor of the host antiviral response by blocking
production of inducible chemokines and IFN-a/b. A major
finding of this work is the demonstration that hMPV G
protein interacts with RIG-I, a cytoplasmic viral sensor. As
result, hMPV G protein inhibits RIG-I-dependent signaling
pathways, including activation of NF-kB and IRF-3, two
transcription factors necessary for the synthesis of
inflammatory and antiviral cytokines. Understanding the
function of hMPV proteins is critical for the future design
of effective antiviral therapies and rationale design of
vaccine candidates.
Role of hMPV G Protein in Innate Immune Responses
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around 80–85% (data not shown). However, there was significant
less F protein expression in rhMPV-DG-infected cells, compared
to rhMPV-WT (Fig. 1B), and viral titers at 6, 15 and 24 h p.i. were
lower (one third to half log less) in A549 cells infected with
rhMPV-DG compared to WT virus, indicating a role of G protein
in hMPV replication in airway epithelial cells.
G protein affects hMPV-induced type I interferon and
pro-inflammatory cytokine and chemokine secretion in
vitro
It was recently shown that rhMPV-DG is highly attenuated in
the lower and upper respiratory tract of animal models of
infection, compared to rhMPV-WT [3,4]. Type I interferons play
a major role in limiting viral replication [reviewed by [17]]. To
determine whether the restriction of rhMPV-DG replication in vivo
could be due to increased IFN-a/b production, airway epithelial
cells were infected with either rhMPV-DG or rhMPV-WT and cell
supernatants were harvested at various time p.i to measure both
IFN-a and b by ELISA. As show in Fig. 2, infection of A549 cells
with rhMPV-DG resulted in a 4-fold and 7-fold increase in IFN-a
secretion at 15 h and 24 h p.i respectively, compared to rhMPV-
WT. Similarly, IFN-b secretion was 13-fold and 20-fold higher in
cells infected with rhMPV-DG at 15 h and 24 h p.i. compared to
cells infected with rhMPV-WT.
To determine whether G protein deletion had a broader effect
on hMPV-induced secretion of pro-inflammatory and immuno-
regulatory molecules, we compared the secretion pattern of
chemokines and cytokines in A549 cells infected with either
rhMPV-WT or rhMPV-DG, using a combination of ELISA and
Bio-Plex assays (Fig. 3). rhMPV-DG induced significantly higher
amounts of the cytokine IL-6, the CXC chemokines IL-8 and IP-
10, and CC chemokines MCP-1, MIP-1a and RANTES at both
15 and 24 h p.i, compared to hMPV-WT. A significant difference
in IL-8 and MIP-1a induction between rhMPV-WT- and rhMPV-
DG-infected cells was noted as early as 6 h p.i.
Modulation of IRF activation by hMPV G protein
Transcription factors of the interferon regulatory factor (IRF)
family have been shown to play an essential role in viral-induced
expression of type I IFN genes (reviewed in [18]). They also
regulate the induction of several other genes involved in the
immune/inflammatory response to viral infections, including
chemokines, such as RANTES and IP-10, and cytokines, such as
IL-15 [Reviewed in [18]]. Among the different members of the
IRF family, IRF-1, -3, -5 and -7 have been identified as direct
transducers of viral-induced signaling, with IRF-3 being necessary
for IFN-b and RANTES gene expression in response to
paramyxovirus infections [19].
To investigate the role of G protein in hMPV-induced type I
interferon expression and IRF protein activation, we initially
determined the effect of G protein deletion on IFN-b gene
transcription using transient transfection assays. A549 cells were
transfected with a reporter plasmid containing the luciferase gene
under control of the IFN-b promoter (IFN-b-LUC) [11], and either
mock infected or infected with rhMPV-WT or -DG. Cells were
harvested at 15 h p.i. to measure luciferase activity. As shown in
Fig. 4A, luciferase activity was significantly higher (3 fold) in A549
cells infected for 15 h with rhMPV-DG, compared to rhMPV-WT.
Enhanced activation of the IFN-b promoter in cells infected with
rhMPV-DG was also observed at 24 h p.i. (data not shown). To
confirm the inhibitory role of G in the induction of IFN-b,w e
infected A549 cells with rhMPV-DG in presence of plasmid
expressing either G or F protein. As shown in Fig. 4A, expression
ofhMPVGbutnotFproteinreversiblyinhibitedtheenhancedIFN-
b gene transcription in response to rhMPV-DG infection. Similarly,
G protein expression significantly decreased IFN-b gene transcrip-
tion induced by RSV, another paramyxovirus (Fig.S1).
To determine whether G protein deletion specifically affected
hMPV-induced IRF-dependent gene transcription, A549 cells
were transiently transfected with a construct containing multiple
copies of the RANTES ISRE site linked to the luciferase reporter
gene [20] and infected with rhMPV-WT or rhMPV-DG. Infection
of rhMPV-DG resulted in significantly higher luciferase activity,
compared to rhMPV-WT, which was significantly inhibited by G
but not F protein expression (Fig. 4B).
IRF-3 activation is necessary for IFN-b and RANTES gene
expression in response to paramyxovirus infections [21,22]. IRF-3
is constitutively expressed and in unstimulated cells appears in two
forms, when resolved by SDS-PAGE, defined as forms I and II
[23]. Following viral infections, IRF-3 undergoes a shift in
molecular weight and migrates as forms III and IV, due to the
virus-induced C-terminal phosphorylation [23], which occurs on
specific serine residues and is necessary for IRF nuclear
translocation, dimerization, binding to DNA and activation of
transcription (Reviewed in [24]). To determine whether changes in
Figure 2. Effect of G protein deletion on type I IFN secretion.
A549 cells were infected with rhMPV-WT or rhMPV-DG, at MOI of 2, and
harvested at 6, 15 and 24 h p.i. to measure secretion of IFN-a and IFN-b
in cell supernatants by ELISA. Data shown are representative of three
independent experiments. *, P,0.05 relative to rhMPV-WT.
doi:10.1371/journal.ppat.1000077.g002
Role of hMPV G Protein in Innate Immune Responses
PLoS Pathogens | www.plospathogens.org 3 May 2008 | Volume 4 | Issue 5 | e1000077abundance of IRF-dependent gene expression, as well as the
increased IRF-driven gene transcription observed in response to
rhMPV- DG infection, resulted from enhanced IRF-3 protein
activation, we investigated IRF serine phosphorylation and
nuclear translocation by Western blot analysis, using nuclear
extracts from control and rhMPV-infected A549 cells (Fig. 4C).
IRF-3 phosphorylation occurred earlier and was significantly
higher in rhMPV-DG infected cells at all time points of infection,
Figure 3. Effect of G protein deletion on cytokine and chemokine secretion. A549 cells were infected with rhMPV-WT or rhMPV-DG, at MOI
of 2, and harvested at 6, 15 and 24 h p.i. to measure secretion of cytokines, CXC chemokines and CC chemokines in cell supernatants by Bio-Plex.
Data shown are representative of three independent experiments. *, P,0.05 relative to rhMPV-WT.
doi:10.1371/journal.ppat.1000077.g003
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PLoS Pathogens | www.plospathogens.org 4 May 2008 | Volume 4 | Issue 5 | e1000077Figure 4. hMPV G protein modulates viral-induced IRF-3 activation. A549 cells were cotransfected with a luciferase reporter plasmid
containing either the human IFN-b promoter (A) or multimers of the RANTES ISRE site (B), and the expression plasmid containing hMPV G or F
protein or the control vector (CV), and infected with rhMPV-WT or -DG, at MOI of 2. Cells were harvested at 15 h p.i. to measure luciferase activity.
Uninfected plates served as controls. For each plate luciferase was normalized to the b-galactosidase reporter activity. Data are representative of two
independent experiments and are expressed as mean6standard error of normalized luciferase activity. *, P,0.05, relative to rhMPV-DG-infected-CV
transfected A549 cells. (C) A549 cells were infected with rhMPV-WT or rhMPV-DG, at MOI of 2, for various lengths of time and harvested to prepare
nuclear extracts. Equal amounts of protein from uninfected and infected cells were analyzed by Western blot using either an anti-Ser396 phospho-
IRF-3 (pIRF-3) or regular anti-IRF-3 antibody. Membranes were stripped and reprobed for lamin b, as control for equal loading of the samples.
Densitometric analysis of IRF band intensity, performed using the histogram function of Adobe Photoshop, is shown after normalization to lamin b.
doi:10.1371/journal.ppat.1000077.g004
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only at 15 and 24 h p.i. (Fig. 4C). The enhanced IRF-3
phosphorylation was paralleled by a significant increase in nuclear
translocation, also observed at all time points of rhMPV-DG
infection, compared to rhMPV-WT (Fig. 4C). Enhanced activation
was also demonstrated by the shift in molecular weight and slower
gel migration of IRF-3 in cells infected with rhMPV-DGa t3 ,6 ,1 5
and 24 h p.i., compared to rhMPV-WT, in which IRF-3 nuclear
translocation and molecular shift occurred only at 15 and 24 h p.i.
G protein modulates hMPV-induced NF-kB activation
NF-kB is a superfamily of ubiquitous transcription factors
composed of NF-kB1 or p50, NF-kB2 or p52, Rel A or p65, RelB
and c-Rel proteins, which can form homo- and hetero-dimers and
produce complexes with various transcriptional activities [25].
Their activation is controlled by accessory inhibitory proteins
called IkBs [26]. NF-kB inducing stimuli cause IkB phosphory-
lation, through activation of the multicomponent IkB kinase (IKK)
complex [25], with subsequent IkB proteolytic degradation [27],
event that allows NF-kB to enter the nucleus and activate target
gene transcription. A number of paramyxovirus-inducible inflam-
matory and immunoregulatory genes require NF-kB for their
transcription, as we have shown in vitro for IL-8 [28], RANTES
[22], as well as other chemokines, cytokine, secreted proteins and
signaling molecules [29].
To determine whether the observed increased in IL-8
production in response to rhMPV-DG infection was due to
enhanced IL-8 gene transcription, A549 cells were transfected with
a construct containing the human IL-8 promoter linked to the
luciferase reporter gene [30] and infected with either rhMPV-WT
or rhMPV-DG. Consistent with IL-8 secretion, rhMPV-DG-
induced IL-8 promoter activation occurred earlier and was
significantly higher (,3 and 1.8 fold increase at 6 and 15 h p.i.)
than rhMPV-WT (Fig. 5A).
To investigate the role of NF-kB in rhMPV-DG-induced
enhanced IL-8 gene transcription, 293 cells were transiently
transfected with a construct containing multiple copies of the IL-8
NF-kB site linked to the luciferase reporter gene [30] and infected
with either rhMPV-WT or -DG. Compared to rhMPV-WT,
infection with rhMPV-DG resulted in significant higher NF-kB-
driven gene transcription at 6 and 15 h p.i., with the most
significant difference occurring at 15 h p.i., which was inhibited by
expression of G but not F protein (Fig. 5B).
We have previously show that p65 and p50 are the two major
NF-kB family members induced by paramyxovirus infection of
airway epithelial cells [28], with p65 being necessary for a variety
of viral-induced chemokines and cytokine gene expression [29].
To determine whether G protein plays a role in modulating
hMPV-induced NF-kB activation, we investigated p65 and p50
nuclear translocation in A549 cells infected with either rhMPV-
WT or -DG. Both viruses induced significant p65 and p50 nuclear
translocation as early as 3h p.i., however the nuclear abundance of
both NF-kB subunits was significantly higher in rhMPV-DG
infected cells, compared to rhMPV-WT (Fig. 5C).
In conclusion, G protein deletion enhanced hMPV-induced
expression of pro-inflammatory and immunoregulatory mediators,
likely through enhanced activation of transcription factors
belonging to the NF-kB and IRF families.
hMPV G inhibits RIG-I-mediated activation of the IFN-b
promoter
The RIG-I/MDA-5/MAVS pathway plays an essential role for
initiating cellular signals leading to the activation of transcription
factors and subsequent induction of type I IFN in the course of viral
infections[13,31,32].Inrecentinvestigations,wefound this pathway
is necessary for hMPV-induced gene expression in airway epithelial
cells [12]. Therefore, we investigated whether the G protein
inhibitory effect on NF-kB and IRF activation and subsequent
induction of pro-inflammatory and anti-viral molecules occurred via
inhibiting RNA helicase-initiated cellular signaling. To do so, A549
cells were transfected with Flag-tagged RIG-I, MDA-5 or MAVS
expression plasmids with a plasmid containing the luciferasereporter
gene under the control of the IFN-b promoter (IFN-b-Luc).
Individual expression of all three signaling molecules significantly
induced IFN-b promoter activation, in the absence of viral infection
(Fig.6A).RIG-I-dependent IFN-b promoteractivation wasinhibited
by G protein expression, while there was no effect on MDA-5- or
MAVS-induced luciferase activity (Fig. 6A).
Next, we investigated whether G protein was able to directly
interact with RIG-I, disrupting its ability to mediate cellular
signaling, as it was recently shown for influenza virus NS1 protein
[33–35]. 293 cells were transfected with V5-tagged G and Flag-
tagged RIG-I expression plasmids. Vectors expressing V5 or Flag
only were used as negative controls. After 30 h of transfection,
cells were lysed followed by immunoprecipitation using anti-V5
antibody (Fig. 6B). The immunoprecipitated complex was
separated on SDS-PAGE and transferred onto PVDF membrane.
Western blot using anti-Flag antibody revealed that RIG-I
coprecipitated with G protein. Reverse immunoprecipitation,
using anti-Flag to precipitate expressed RIG-I and then using
anti-V5 antibody for Western blot also confirmed that G was
present in the immuno-precipitated complex (Fig. 6B). A similar
experiment performed using a V5-tagged F expression plasmid,
instead of G, and Flag-tagged RIG-I did not show any interaction
between the two proteins (Fig. S2).
To confirm that G interacts with RIG-I in conditions of naı ¨ve
protein expression, A549 cells were mock infected or infected with
rhMPV-WT or rhMPV-DG. For each condition, half sample was
coimmunoprecipitated using anti-RIG-I antibody, while the other
half was exposed to an isotype antibody to rule out nonspecific
proteinbindingduringtheimmunoprecipitation.Twospecificbands
around 90 and 50 kD were detected in rhMPV-WT-infected
samples, but not in the mock infected or rhMPV-DG samples, using
an anti-hMPV antiserum, likely corresponding to the two major
glycosylated forms of G protein (Fig. 6C), as described in [3]. The
same size bands were detected by the anti-hMPV antiserum when G
was expressed in 293 cells, while the F protein, used as a control, run
with a different molecular weight (Fig. S3).
Discussion
The innate immune response represents a critical component of
the host defense against viruses and is coordinated at the cellular
level by activation of transcription factors that regulate the
expression of inducible gene products with antiviral and/or
inflammatory activity. As the immune system evolved to fight
viral infections, so viruses developed strategies to evade the host
immune responses, mainly by targeting the type I interferon
system. HMPV is the second most common cause of epidemic
respiratory infections in infants and young children and a
significant cause of respiratory tract infections in the elderly and
immunocompromised patients. The availability of the reverse
genetic system for negative sense RNA viruses has allowed the
dissection of viral protein functions in viral replication as well as in
cellular signaling. As a recently identified virus, little is known
about the role of individual hMPV proteins in modulating host cell
responses. In this study, we found that hMPV infection of airway
epithelial cells, the primary target of hMPV infection [36,37],
Role of hMPV G Protein in Innate Immune Responses
PLoS Pathogens | www.plospathogens.org 6 May 2008 | Volume 4 | Issue 5 | e1000077Figure 5. hMPV G protein modulates viral-induced NF-kB activation. (A) A549 cells were transfected with a luciferase reporter plasmid
containing the human IL-8 promoter and infected with rhMPV-WT or -DG, at MOI of 2. Cells were harvested at 15 h p.i. to measure luciferase activity.
Uninfected plates served as controls. For each plate luciferase was normalized to the b-galactosidase reporter activity. Data are representative of two
independent experiments and are expressed as mean6standard deviation of normalized luciferase activity. *, P,0.05 relative to rhMPV-WT. (B) A549
cells were transfected with a luciferase reporter plasmid containing multimers of the IL-8 NF-kB site together with G or F protein expression plasmid
or thes empty vector and infected with rhMPV-WT or -DG, at MOI of 2. Cells were harvested at 15 h p.i. to measure luciferase activity. Uninfected
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well as type I interferons, whose expression is coordinated by
subsets of transcription factors belonging to the NF-kB and IRF
families. Surprisingly, deletion of G protein resulted in enhanced
production of chemokines and type I interferon (IFN), as well as
increased activation of both families of transcription factors. The
enhanced responses to rhMPV-DG infection were not due to an
increasedabilityofrhMPV-DG to replicate, as the accumulation of F
proteinininfectedairwayepithelialcellsandviraltiterswerelowerin
cells infected with rhMPV-DG, compared to rhMPV-WT.
Circumvention of the IFN response occurs through different
strategies. Two major categories include either direct suppression
of IFN production or interference with IFN signaling, through
inhibition of the JAK/STAT pathway. The kinetics of enhanced
chemokine and IFN production and transcription factor activation
in response to rhMPV-DG infection, which occurred at early time
points of infection, suggested that G protein regulated an early
signaling event triggered in response to hMPV infection of airway
epithelial cells.
RIG-I and MDA-5 are two RNA helicases that have been
recently identified as fundamental sensors of viral infections [10,38].
They recognize single and double-stranded RNA and their
engagement triggers a signaling cascade leading to NF-kBa n d
IRF activation, through interaction with the mitochondrial antiviral
signaling (MAVS) adaptor molecule [39]. Several viral proteins
have been shown to be able to disrupt the RIG-I/MDA-5/MAVS
signaling pathway by sequestering viral RNA from helicase binding
and/or disrupting helicase interaction with downstream signaling
molecules or by increasing protein degradation. Influenza A NS1
protein employs the first two mechanisms to block RIG-I-mediated
IFN induction [40]. Similarly, V proteins of paramyxoviruses have
been shown to bind MDA-5 and inhibit IFN-b production [13]
[41]. On the other hand, poliovirus infection induces MDA-5
degradation, also inhibiting IFN induction [42,43]. HCV 3/4A
proteases cleave MAVS at the level of mitochondria insertion,
releasing the protein to the cytoplasmic compartment, therefore
preventing further transmission of RIG-I-dependent signaling,
resulting in the inhibition of host’s antiviral responses [39]. In this
study, we found that hMPV G protein physically interacts with
RIG-I and inhibits RIG-I, but not MDA-5 and MAVS-induced
IFN-b transcription, justifying the broad inhibitory effect of G
protein on activation of NF-kB and IRF transcription factors and
induction of antiviral and pro-inflammatory molecules.
The inhibitory effect of hMPV G protein on cellular signaling
could be a common feature of surface glycoproteins of enveloped
single strand, negative strand RNA viruses. RSV G protein has been
shown to modulate cytokine and chemokine production, as infection
with a mutant RSV lacking the full-length G protein or the soluble
part of G protein (sG) enhanced production of IL-6 and IL-8 in
monocytes [6], as well as IL-8 and RANTES secretion and ICAM
expression in airway epithelial cells [7]. RSV-DGa l s oc a u s e dm o r e
lung inflammation, compared to WT, in a mouse model of infection
[6]. The G protein of pneumonia virus of mice, a murine relative of
RSV, has also been recently identified as an important virulence
factor, as viral replication of a recombinant mutant virus lacking G is
severely restricted in a BALB/c mouse model of infection [44].
Similarly, the surface glycoproteins of hantaviruses, in particular the
ones associated with hemorrhagic pulmonary syndrome (HPS), have
been shown to affect IRF-3 activation and IFN production, via
interaction with RIG-I and TBK-1, a kinase responsible for viral-
induced IRF-3 phosphorylation, as well as to inhibit IFN-mediated
cellular responses [45,46].
hPMV infection is associated with production of inflammatory
mediators not only in vitro but also in vivo [47]. The high
attenuation of rhMPV-DG replication in the lower respiratory
tracts of rodent models of infection suggest that it could be
developed as a vaccine candidate [3] [4]. Our findings suggest that
careful investigation is needed in an animal model of infection to
address whether rhMPV-DG can cause enhance lung inflamma-
tion and impaired lung function, as recently shown for RSV
lacking the G protein [6,48].
In summary, this study provides us with novel information on
the role of hMPV G protein in regulating host cell responses.
Further studies are needed to determine the exact mechanism by
which G protein inhibits RIG-I activation and to define the
domains/amino acid residues mediating RIG-I and G interaction.
Materials and Methods
Viral preparation
LLC-MK2 cells (ATCC, Manassas, VA) were maintained in
MEM (Invitrogen GIBCO, Carlsbad, CA) supplemented with
10% fetal bovine serum and Penicillin and Streptomycin (100 U/
ml). The Canadian isolate hMPV83 and its derived recombinant
viruses were propagated in LLC-MK2 cells at 35uC in the absence
of serum and in the presence of 1 mg of trypsin/ml (Worthington,
Lakewood, NJ), and were sucrose purified, as previously described
[47]. Viral titer was determined by immunostaining in LLC-MK2
cells, as previously described [49].
Cell culture and infection of epithelial cells with hMPV
A549, human alveolar type II-like epithelial cells, and 293, a
human embryonic kidney epithelial cell line (both from ATCC,
Manassas, VA), were maintained in F12K and MEM medium
respectively, containing 10%(v/v) FBS,10 mMglutamine,100 IU/
ml penicillin and 100 mg/ml streptomycin. Cell monolayers were
infected with hMPV at multiplicity of infection (MOI) of 2 in serum-
free medium containing antibiotics and 1 mgo ft r y p s i n / m lf o ra l l
experiment, unless otherwise stated. An equivalent amount of
sucrose solution was added to uninfected A549 cells, as control. BSR
T7/5 cells, baby hamster kidney cells that constitutively expressing
the T7 RNA polymerase, were a gift from Dr. Conzelmann,
Munich, Germany. They were maintained in Glasgow minimal
essential medium (MEM) supplemented with 1% amino acids, 10%
fetal bovine serum, 12 mg/L tryptose phosphate broth, 1 mg/ml of
Geneticin, and 100 U/ml of Penicillin and Streptomycin.
Construction antigenome and support protein plasmids
for viral recovery
A plasmid encoding hMPV antigenome was constructed as
described in Biacchesi et al. [16], with some modifications. Briefly,
viral RNA was purified from hMPV CAN83-infected LLC-MK2
plates served as controls. For each plate luciferase was normalized to the b-galactosidase reporter activity. Data are representative of two
independent experiments and are expressed as mean6standard deviation of normalized luciferase activity. *, P,0.05 relative to rhMPV-DG-infected-
CV transfected A549 cells. (C) A549 cells were infected with rhMPV-WT or rhMPV-DG, at MOI of 2, for various lengths of time and harvested to prepare
nuclear extracts. Equal amounts of protein from uninfected and infected cells were analyzed by Western blot using either an anti-p50 or anti-p65
antibody. Membranes were stripped and reprobed for lamin b, as control for equal loading of the samples. Densitometric analysis of NF-kB band
intensity, performed using the histogram function of Adobe Photoshop, is shown after normalization to lamin b.
doi:10.1371/journal.ppat.1000077.g005
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strand cDNA was then generated using Superscript III reverse
transcriptase (Invitrogen Carlsbad, CA). PCR was carried out
using Pfu DNA polymerase (Stratagene, La Jolla, CA) following
manufacturer’s instruction. The complete hMPV antigenome
cloned in pBSKSII vector (a gift from Dr. Buchholz, NIAID,
Bethesda) was obtained by sequential ligation of three fragments
amplified from the cDNA template. Fragment I was first cloned
using forward primer: 59-ACGCGAAAAAAACGCGTATAAAT-
TAAGTTAC-39 and reverse primer: 59- TTTGTCCCGTT-
CTTGATTgctAgCATTCTTATTCTAACTTg-39. The cloned
fragment which contains the putative N, P, and M genes was
first cloned into TOPO cloning vector (Invitrogen, Carlsbad, CA).
On the downstream end of this fragment, an NheI site was created
by four nucleotide substitutions in the putative M–F intergenic
region as a marker to distinguish between cDNA-derived and
biologically derived hMPV. In order to insert a T7 RNA
polymerase promoter (T7p) at the 39 end of the antigenome,
fragment I inserted TOPO was used as template to clone the T7p-
fragment I using same reverse primer and forward primer: 59-
cgcgacgtcTAATACGACTCACTATAGGGACGCGAAAAAAA-
CGCGTATAAATTAAGTTAC-39. Italicized letters indicate
restriction enzyme site. Underlined letters indicate T7 RNA
polymerase promoter (T7p) sequence. Construction of fragment
II, which contains F, M2, SH and G) and fragment III, containing
L and part of the hepatitis delta virus ribozyme, was done as
described in Biacchesi et al. [16]. Construction of G deleted mutant
cDNA was done as described in Biacchesi et al. [3].
hMPV cDNA was also used as a template to clone the support
genes necessary for the virus recovery, as described in Biacchesi et
al. [16]. Amplified PCR fragments, encoding N, P and M2-1, were
first inserted into TOPO cloning vector (Invitrogen, Carlsbad,
CA), and then restricted with AflIII/XhoI. PCR fragments were
then subcloned into NCoI/XhoI digested PTM1, a T7 promoter
containing vector (a generous gift from Dr. Moss at NIH). For the
N protein, site-directed mutagenesis was performed to silently
mutate an AflIII site before cloning the gene into PTM1. To clone
the polymerase L, full length L cloned in TOPO vector was cut
first with BamHI and blunt ended using T4 DNA polymerase
(Invitrogen, Carlsbad, CA) following manufacturer’s instruction.
PTM1 was also cut first with NcoI and then blunted using T4
DNA polymerase as well. Both vectors were then cut with XhoI
Figure 6. Inhibition of RIG-I-mediated signaling by G protein.
(A) A549 cells were transfected with a luciferase reporter plasmid
containing the human IFN-b promoter, plasmids encoding either RIG-I,
MDA-5 or MAVS or their control vectors, and a plasmid expressing
hMPV G or the empty vector (as indicated at the bottom of each
column). Cells were harvested 30 h post-transfection to measure
luciferase activity. For each plate luciferase was normalized to the a ˆ-
galactosidase reporter activity. Data are representative of two
independent experiments and are expressed as mean6SD of normal-
ized luciferase activity. *, P,0.05 relative to pCAGGS+RIG-I group. BG:
background; CV: control vector. (B) 293 cells were transfected with
plasmids encoding Flag-tagged RIG-I and V5-tagged G or their control
vectors. Total cell lysates were immunoprecipitated with anti-V5
antibody followed by Western blot using anti-Flag antibody to detect
RIG-I. Reverse immunoprecipitation was also done, where RIG-I was
immunoprecipitated using anti-Flag antibody and G protein was then
detected using anti-V5 antibody. Membranes were stripped and
reprobed to check for proper expression of G and RIG-I. (C) A549 cells
were mock infected or infected with rhMPV-WT or -DG, MOI of 2, and
harvested at 24 h p.i. to prepare total cell lysates. Samples were
subjected to immunoprecipitation using anti-RIG-I antibody or control
isotype. The immunoprecipitated complexes were then subjected to
SDS-PAGE followed by Western blot using anti-hMPV antibody.
Membrane was then stripped and reprobed with anti-RIG-I antibody
to determine levels of immunoprecipitated RIG-I. Numbers on the left
side represent molecular weight marker size expressed in kilodalton.
Arrows indicate bands corresponding to hMPV G protein.
doi:10.1371/journal.ppat.1000077.g006
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XhoI site of PTM1. The plasmids containing the full-length
hMPV-WT or -DG antigenome or individual support genes were
sequenced to verify the absence of significant mutations. Primer
sequence for cloning the recombinant viruses, as well as the
support viral proteins, are available upon request.
Recovery of recombinant hMPV
Confluent BSR T7/5 cells in six-well dishes were transfected
with 5 mg of antigenomic plasmid corresponding to hMPV wild-
type (rhMPV-WT), or one lacking G (rhMPV-DG) gene, together
with 1–2 mg of PTM1 expressing P and N proteins, and 0.5–1 mg
of PTM1 expressing M2-1 and L proteins. Lipofectamine 2000
(Invitrogen) was used as transfection reagent, according to
manufacturer’s instructions. After overnight incubation at 35uC,
transfection medium was removed and replaced with Glasgow
MEM without trypsin or serum. Trypsin was added on day 3 post-
transfection to a final concentration of 1 mg/ml, then cell-medium
mixtures were passaged onto fresh LLC-MK2 cells and incubated
at 35uC for the next few days. Typical viral CPE were usually
observed around day 5–6 post-infection (p.i.). Recombinant virus
generation was confirmed by restriction digestion and the
sequencing of viral RNA, as described in Biacchesi et al. [16].
The recovered viruses were then amplified for two passages in
LLC-MK2 cells and saved as stock viral preparations. Viruses with
no more than 4–5 passages were used in all experiments.
Plasmid construction for G expression
G protein was cloned using the plasmid encoding hMPV
antigenome as a template. PCR was carried out using Pfu DNA
polymerase (Stratagene, La Jolla, CA) following manufacturer’s
instruction. The primer sequences for V5-tagged G were: forward:
59- ACGCgaattcATGGAGGTGAAAGTAGAGAA-39, and re-
verse: 59-T ctcgagTCACGTAGAATCGAGACCGAGGAGAGG-
GTTAGGGATAGGCTTACCGTTTTGCATTGTGCTTAC-
AGATGCCTG-39. Italicized letters indicate restriction enzyme
site. Underlined letters indicate V5 sequence. The cloned V5-
tagged G was first cloned into the TOPO cloning vector, and then
cut by EcoRI and XhoI and subcloned into pCAGGS vector.
Sequence integrity was verified by sequencing performed by the
protein chemistry laboratory at UTMB.
Reporter gene assays
Plasmids containing either the IFN-b promoter, as well as
plasmids containing multiple copies of the IL-8 NF-kBs i t eo ro f
the RANTES ISRE site, linked to the luciferase reporter gene, have
been previously described [11,20,22,30]. Logarithmically growing
A549 or 293 cells were transfected in triplicate with the reporter
plasmids using FuGene 6 (Roche, Indianapolis, IN), as previously
described [22]. The next day cells were infected with recombinant
hMPV, either WT or DG, at MOI of 2. Uninfected plates served as
control. At various times post-infection, cells were lysed to measure
independently luciferase and b-galactosidase reporter activity, as
previously described [50]. Luciferase was normalized to the internal
control b-galactosidase activity. All experiments were performed in
duplicate or triplicate. In the experiments, in which the role of
overexpressed G in modulating viral-induced response was investi-
gated, a plasmid encoding G or its control vector was cotransfected
with these luciferase reporter genes.
Coimmunoprecipitation
293 cells with 60–70% confluence in 6-well plate were
cotransfected with 0.5 mg of pcDNA6 containing Flag-tagged
RIG-I and 0.1 mg of either pCAGGS encoding V5-tagged G
protein or the empty vector, used as a negative control. Cells were
harvested 30 h after transfection and immunoprecipitation was
carried out using immunoprecipitation Kit from Roche (Cat #
11719, Indianapolis, IN). In brief, 6610
6 cells were lysed using
1.5 ml of lysis buffer. To reduce background caused by non-
specific adsorption of irrelevant cellular proteins to protein A/G-
agarose, a preclearing step was performed by incubating the
sample with 50 ml of the protein A/G-agarose for 3 h at 4uCo na
rocking platform. Precleared samples were then exposed to 5 mgo f
antibody against either V5 (Invitrogen, Carlsbad, CA) or Flag
(Sigma, St. Louis, MO) or to an isotype antibody control, for 1 h
at 4uC. 50 ml of the protein A/G-agarose were added to the
samples and incubated overnight at 4uC. Immunecomplexes were
recovered by centrifugation and washed three times using buffers
with different ion strength provided by the kit. The immunopre-
cipitated complexes were eluted from the beads and subjected to
SDS-PAGE and Western blot analysis. To investigate the
interaction of endogenous RIG-I with G protein during hMPV
infection, confluent A549 cells in 6-well plate were mock infected
or infected with rhMPV-WT or -DG, at MOI of 2 for 24 h. Cells
were lysed and immunoprecipitated using anti-RIG-I antibody
(Abgent, San Diego, CA, cat.#AP1900a) or isotype control
antibody, as described above. The presence of G protein in the
complex was then detected using polyclonal anti-hMPV antibody,
a gift from Medimmune, Mountain View, CA.
Western blot
Nuclear extracts of uninfected and infected cells were prepared
using hypotonic/nonionic detergent lysis, according to Schaffner
protocol [51]. To prevent contamination with cytoplasmic proteins,
isolated nuclei were purified by centrifugation through 1.7 M
sucrose buffer A for 30 min, at 12,000 rpm, before nuclear protein
extraction, as previously described [52]. Total cell lysates of
uninfected and infected cells were prepared by adding ice-cold lysis
buffer (50 mM Tric-HCl, pH 7.4, 150 mM NaCl, 1 mM EGTA,
0.25% sodium deoxycholate, 1 mM Na3VO4, 1 mM NaF, 1%
Triton X-100 and 1 mg/ml of aprotinin, leupeptin and pepstatin).
After incubation on ice for 10 min, the lysates were collected and
detergent insoluble materials were removed by centrifugation at 4uC
at 14,000 g. After normalizing for protein content, using Bio-Rad,
Hercules, CA. Nuclear extracts or total cell lysates were fractionated
by SDS-PAGE, and transferred to polyvinylidene difluoride
membranes. Membranes were blocked with 5% milk in TBS-
Tween and incubated with the proper primary antibodies according
to manufacturer’s instruction. Primary antibodies used for IRF-3
and phosphorylated IRF-3 detection was from Santa Cruz (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) and Upstate (Upstate,
Lake Placid, NY) respectively. Rabbit anti-p65 and p50 were
purchase from Cell Signaling (Cell Signaling Technology, Inc,
Danvers, MA). Monoclonal anti-hMPV F was a gift from
Medimmune, Mountain View, CA. Proper horseradish-coupled
secondary antibody was then used and proteins detected by
enhanced chemiluminescence assay (Amersham, Piscataway, NJ).
Bio-Plex and ELISA
IFN-a and -b concentrations were determined by commercial
enzyme-linked immunosorbent assays (ELISA), according to the
manufacturer’s instructions (PBL, Piscataway, NJ). Chemokines
and cytokines (IL-1RA, IL-1b, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9,
IL-10, IL-12 p70, IL-13, IL-17, G-CSF, GM-CSF, IFN-c, IP-10,
EOTAXIN, MIP-1a, MIP-1b, GCSF, FGFB, PDGF, VEGF and
TNF-a) were quantified by Luminex-based Bio-Plex system (Bio-
Rad Laboratories, Hercules, CA) according to the manufacturer’s
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measured by Bio-Plex is 3 pg/ml.
Statistical analysis
Statistical significance was analyzed by using analysis of
variance (ANOVA). P value of less than 0.05 was considered
significant. Results are shown as mean6SEM.
Supplementary materials and methods
Recombinant human RSV preparation. Vero cells
(ATCC, Manassas, VA) were maintained in MEM (Invitrogen
GIBCO, Carlsbad, CA) supplemented with 5% fetal bovine serum
and Penicillin and Streptomycin (100 U/ml). A2 strain derived
human recombinant RSV lacking NS1 and NS2 was kindly
provided by Dr. Hong (Medimmune, Gaithersburg, MD) and was
propagated in Vero cells at 35uC in the presence of 1% fetal
bovine serum. The viruses were sucrose purified, as previously
described [47].
Plasmid construction for F expression. F protein was
cloned using the plasmid encoding hMPV antigenome as a
template. PCR was carried out using Pfu DNA polymerase
(Stratagene, La Jolla, CA) following manufacturer’s instruction.
The primer sequences for F were: forward: 59- ACGCgaattc-
ATGTCTTGGAAAGTGGT -39, and reverse: 59-T ctcgagAC-
TGTGTGGTA TGAAGC -39. Italicized letters indicate
restriction enzyme site. The cloned F was first cloned into the
TOPO cloning vector, and then cut by EcoRI and XhoI and
subcloned in frame into pcDNA6 vector containing V5. The V5-
tagged F then was cut from pcDNA6 and subcloned into
pCAGGS vector. Sequence integrity was verified by sequencing
performed by the protein chemistry laboratory at UTMB.
Supporting Information
Figure S1 G protein inhibits rhRSV-DNS1/NS2-induced IFN-
b transcription. Logarithmically growing A549 cells were trans-
fected with a luciferase reporter plasmid containing the human
IFN-b promoter together with a plasmid expressing hMPV G or
the empty vector. After 24 h post transfection, cells were mock
infected or infected with recombinant human RSV lacking NS1
and NS2 (rhRSV-DNS1/NS2) at MOI of 1. Cells were harvested
at 24 h p.i. to measure luciferase activity. For each plate luciferase
was normalized to the b-galactosidase reporter activity. Data are
expressed as mean6SD of normalized luciferase activity. CV:
control vector. *, P,0.05 relative to CV+ rhRSV-DNS1/NS2.
Found at: doi:10.1371/journal.ppat.1000077.s001 (0.37 MB TIF)
Figure S2 RIG-I does not interact with hMPV F protein. 293
cells were transfected with plasmids encoding Flag-tagged RIG-I
and V5-tagged F or their control vectors. Total cell lysates were
immunoprecipitated with anti-Flag antibody followed by Western
blot using anti-V5 antibody to detect hMPV F. Membranes were
stripped and reprobed to check for proper expression and
immunoprecipitation of RIG-I.
Found at: doi:10.1371/journal.ppat.1000077.s002 (1.54 MB TIF)
Figure S3 hMPV G and F proteins migrate differently on SDS-
PAGE. 293 cells were transfected with a plasmid encoding G (lane
2) or F (lane 4) or their control vector (lane 1 and 3). At 30 h post-
transfection, cells were harvested using SDS sample buffer. G and
F protein expression was then detected using an anti-hMPV
polyclonal antibody.
Found at: doi:10.1371/journal.ppat.1000077.s003 (0.79 MB TIF)
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